Option chain shows key data for Abivax's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Abivax.

Abivax (NASDAQ:ABVX) Stock, Option Chain

Abivax

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. They are evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two most common forms are UC and CD.

Support from Other Analysts

News

Initiation

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

ABVX

BITF

COHR

EHTH

VEEV

This Veeva Systems Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

xr:d:DAFfISjXLTA:2,j:2114733954,t:23040409

Movers

ABSI

AMCX

HUMA

INFN

Larimar Therapeutics, Inc. - Common Stock

LRMR

AMC Networks, Louisiana-Pacific And Other Big Stocks Moving Lower In Monday&#39;s Pre-Market Session

Abivax SA

<p>Barclays  analyst Dan Levy   maintains Lear (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEA#NYSE">LEA</a>) with a Equal-Weight and lowers the price target from $120 to $115.</p>


Price Target

Barclays Maintains Equal-Weight on Lear, Lowers Price Target to $115

United Airlines CEO Says International Environment Is Going To Be Far Stronger For Longer; Structural Supply Constraints Are Going To Last At Least For The Rest Of This Decade; Wide Body Supply, Both Airframes And Engines, Is Even More Challenged Than Narrow Bodies; Cost Convergence Has Been The Most Impactful At The Big High-Cost Airports In The Country

<p>Guggenheim  analyst Howard Ma   reiterates Dynatrace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DT#NYSE">DT</a>) from Neutral to Neutral.</p>


Reiteration

Guggenheim Reiterates Neutral on Dynatraceto Neutral

<p>Barclays  analyst Dan Levy   maintains BorgWarner (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWA#NYSE">BWA</a>) with a Overweight and lowers the price target from $47 to $43.</p>


Barclays Maintains Overweight on BorgWarner, Lowers Price Target to $43

Biotech

General

SDZNY

TEVA

FDA Adds Boxed Warning About Anaphylaxis With Multiple Sclerosis Medicine Glatiramer Acetate (Copaxone, Glatopa)

<p>Guggenheim  analyst Joseph Osha   reiterates First Solar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>) with a Buy and maintains $335 price target.</p>


FSLR

Guggenheim Reiterates Buy on First Solar, Maintains $335 Price Target

<p>Barclays  analyst Dan Levy   maintains Aptiv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APTV#NYSE">APTV</a>) with a Overweight and lowers the price target from $80 to $75.</p>


APTV

Barclays Maintains Overweight on Aptiv, Lowers Price Target to $75

Macro Economic Events

Market Summary

Bonds

Economics

NFLX

NVDA

Benzinga Market Summary: AI Stocks Rise On Stargate AI Investment, Netflix Rises On Strong Earnings And Price Hike, 10-Year Treasury Yield Rises

<p>Barclays  analyst Dan Levy   maintains American Axle &amp; Mfg Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXL#NYSE">AXL</a>) with a Equal-Weight and lowers the price target from $8 to $7.</p>


Barclays Maintains Equal-Weight on American Axle & Mfg Hldgs, Lowers Price Target to $7

Options

RIVN

Rivian Automotive Option Alert: Feb 21 $16 Calls Sweep (16) Near The Ask: 1000 @ $0.32 vs 10551 OI; Earnings 2/20 After Close Ref=$12.9276

<p>Barclays  analyst Dan Levy   maintains Adient (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADNT#NYSE">ADNT</a>) with a Equal-Weight and lowers the price target from $24 to $21.</p>


ADNT

Barclays Maintains Equal-Weight on Adient, Lowers Price Target to $21

MCTR

Trading Halt: Halt status updated at 10:35:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation

Global

Abbott Exec Says Co Expects To See An Unfavorable Impact Of About 2.5% On 2025 Sales Due To A Stronger Dollar; Co May See A Change On The Regulatory Environment Which Creates Opportunity In M&A; Sees Headwinds Related To Volume-Based Procurement In China To Remain In 2025

<p><strong>Interactive Brokers Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBKR#NASDAQ">IBKR</a>) </strong>reported better-than-expected <a href="https://www.benzinga.com/25/01/43123945/customer-accounts-and-trading-volume-soar-ibkrs-q4-results-shines">fourth quarter- results</a>.</p>
<p>The company reported its quarterly results amid an <a href="https://www.benzinga.com/earnings">exciting earnings season</a>. Here are some key analyst takeaways.</p>
<p><strong>Goldman Sachs On Interactive Brokers</strong></p>
<p><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/6149a1cd46584a00014583f4/james-yaro">Analyst James Yaro</a> maintained a Buy rating, while raising the price target from $214 to $226.</p>
<p>Interactive Brokers reported its fourth-quarter adjusted earnings at $2.02 per share, beating consensus of $1.86 per share, Yaro said in a note. The results were "well-rounded," as the earnings beat was driven by 4% better net revenues and a beat of 230 basis points on margin, he added.</p>
<p>"Looking ahead, the company expects to conduct a number of new programming projects, and plans to increase the marketing budget, both of which should support strong account growth, around which management sounded a constructive tone," the analyst wrote. </p>
<p>Given the company's guidance of lower compensation expenses as well as lower execution and clearing expenses, he raised the pre-tax margin estimate for 2025 and 2026 by 1.3 percentage points to 72.8% and by 1.2 percentage points to 72.4%.</p>
<p><strong>Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.</strong></p>
<p><strong>Piper Sandler Sachs On Interactive Brokers</strong></p>
<p><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/64a548c0943f950001b31bb8/patrick-moley">Analyst Patrick Moley</a> reiterated an Overweight rating, while lifting the price target from $200 to $210.</p>
<p>Interactive Brokers recorded an earnings beat "primarily driven by other income, Moley said. While commission and execution fees came in-line, the company's fixed expenses were around 3% "below our forecast," he added.</p>
<p>Annualized accounts grew by 28% in the fourth quarter and by 30% for the full year, the analyst stated. Interactive Brokers is "the best positioned U.S. brokerage platform to benefit from global growth in retail trading," he further wrote.</p>
<p><strong>Keefe, Bruyette &amp; Woods On</strong> <strong>Interactive Brokers</strong></p>
<p><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/58f614b80bd9910001a77aea/kyle-voigt">Analyst Kyle Voigt</a> reiterated a Market Perform rating and price target of $195.</p>
<p>According to Voigt, Interactive Brokers reported adjusted net revenues of $1.42 billion, exceeding the consensus estimate of $1.37 billion, primarily due to higher Other Income. However, the company&#8217;s net interest income totaled $807 million, coming in slightly below the consensus estimate of $811 million.</p>
<p>The company's expenses totaled $347 million, coming in below the consensus estimate of $367 million, the analyst stated. "Total fixed expenses grew by +6% YoY on a reported basis in 4Q24," he further wrote.</p>
<p><strong>IBKR Price Action:</strong> Shares of Interactive Brokershad were up 6.5% to $205.54 at the time of publication on Wednesday.</p>
<p><strong>Read More: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/12/42740273/nvidia-goldman-sachs-jefferies-financial-and-a-leading-brokerage-firm-on-cnbcs-final-trades">Nvidia, Goldman Sachs, Jefferies Financial And A Leading Brokerage Firm On CNBC&#8217;s &#8216;Final Trades&#8217;</a></strong></li>
</ul>
<p><em>Photo: Shutterstock</em></p>


Analyst Color

Long Ideas

IBKR

Interactive Brokers Delivers 'Well-Rounded' Earnings Beat, Analysts See Global Retail Trading Growth Ahead

BNY CEO Robin Vince Says President Trump Is Clearly Trying To Attract Investment Into The Us He Wants To Drive The Us Economy Forward; On Bank Deregulation Says We Need Stability, We Need A Level Playing Field And We Need Some Predictability; Fixed Income Markets Matter; The World Needs A Lot Of Fixed Income Capital To Expect Rates To Stay High

<p>Barclays  analyst Dan Levy   downgrades Ford Motor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) from Overweight to Equal-Weight and lowers the price target from $13 to $11.</p>


Downgrades

Barclays Downgrades Ford Motor to Equal-Weight, Lowers Price Target to $11

<p><strong>President Donald Trump's </strong>decision to revoke <strong>President Joe Biden&#8217;s</strong> executive order targeting 50% <strong>electric vehicle (EV)</strong> adoption by 2030 has <a href="https://www.benzinga.com/etfs/sector-etfs/25/01/43113169/trumps-ev-rollback-might-shake-up-etfs-winners-losers-and-teslas-unique-role-in-shifting-market">shaken the EV industry</a>, sending shares of <strong>ChargePoint Holdings Inc</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHPT#NYSE">CHPT</a>) lower by around 3% to $1.06 since Tuesday&#8217;s session open.</p>
<p><strong>What To Know:</strong> The rollback <a href="https://www.benzinga.com/etfs/sector-etfs/25/01/43113169/trumps-ev-rollback-might-shake-up-etfs-winners-losers-and-teslas-unique-role-in-shifting-market">signals</a> potential reductions in federal EV subsidies, relaxed emissions standards and limitations on state-level emissions waivers, all of which could dampen EV adoption in the United States.</p>
<p><strong>Read Also: <a href="https://www.benzinga.com/trading-ideas/25/01/43116755/trumps-plan-to-end-7500-ev-tax-credits-could-be-devastating-for-telsa-rivals-poll-says-could-be-bullish-for-elon-musks-company">Trump&#8217;s Plan To End $7,500 EV Tax Credits Could Be &#8216;Devastating&#8217; For Telsa Rivals, Poll Says Could Be Bullish For Elon Musk&#8217;s Company</a></strong></p>
<p>ChargePoint, a leading EV charging network, faces direct exposure to reduced EV adoption. Fewer EV purchases could translate into slower charging infrastructure expansion, impacting the company's growth trajectory. </p>
<p>Furthermore, the potential rollback of federal tax credits for EV buyers may discourage consumer adoption, leading to lower utilization rates for charging networks.</p>
<p>ChargePoint's near-term prospects could now clouded by policy uncertainty. Investors are closely watching state-level responses to federal policy shifts for signs of resilience in the EV ecosystem.</p>
<p><strong>Read Also: <a href="https://www.benzinga.com/trading-ideas/short-ideas/25/01/42985694/chargepoint-outpaces-tesla-in-ev-network-market-share-but-jpmorgan-stays-cautious">ChargePoint Outpaces Tesla In EV Network Market Share, But JPMorgan Stays Cautious</a></strong></p>
<h2 class="wp-block-heading">How To Buy CHPT Stock</h2>
<p>Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. </p>
<p>For example, in ChargePoint Holdings case, it is in the Industrials sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.</p>
<p>According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, CHPT has a 52-week high of $2.44 and a 52-week low of $1.02.</p>
<p><em>Image courtesy of ChargePoint</em></p>


CHPT

What's Going On With ChargePoint (CHPT) Stock?

<p>Financial giants have made a conspicuous bullish move on Western Digital. Our analysis of options history for Western Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDC#NASDAQ">WDC</a>) revealed 12 unusual trades.</p>
<p>Delving into the details, we found 58% of traders were bullish, while 41% showed bearish tendencies. Out of all the trades we spotted, 5 were puts, with a value of $198,252, and 7 were calls, valued at $501,737.</p>
<h3>Projected Price Targets</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $63.0 and $80.0 for Western Digital, spanning the last three months.</p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Western Digital's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Western Digital's significant trades, within a strike price range of $63.0 to $80.0, over the past month.</p>
<h3>Western Digital Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1737559844_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>WDC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$6.15</td>
<td>$5.9</td>
<td>$6.1</td>
<td>$80.00</td>
<td>$183.0K</td>
<td>68</td>
<td>302</td>
</tr>
<tr>
<td>WDC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$3.05</td>
<td>$2.78</td>
<td>$2.87</td>
<td>$72.50</td>
<td>$83.5K</td>
<td>10.8K</td>
<td>304</td>
</tr>
<tr>
<td>WDC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$1.66</td>
<td>$1.61</td>
<td>$1.66</td>
<td>$65.00</td>
<td>$83.0K</td>
<td>4.2K</td>
<td>2.5K</td>
</tr>
<tr>
<td>WDC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/24/25</td>
<td>$2.5</td>
<td>$2.5</td>
<td>$2.5</td>
<td>$68.00</td>
<td>$75.0K</td>
<td>3.7K</td>
<td>1.1K</td>
</tr>
<tr>
<td>WDC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/24/25</td>
<td>$2.0</td>
<td>$1.75</td>
<td>$2.0</td>
<td>$68.00</td>
<td>$64.6K</td>
<td>3.7K</td>
<td>388</td>
</tr>
</tbody>
</table>
</p>
<h3>About Western Digital</h3>
<p>Western Digital is a leading vertically integrated supplier of data storage solutions, spanning both hard disk drives and solid-state drives. In the HDD market it forms a practical duopoly with Seagate, and it is the largest global producer of NAND flash chips for SSDs in a joint venture with competitor Kioxia.</p>
<h3>Present Market Standing of Western Digital</h3>
<ul>
<li>With a volume of 1,783,289, the price of WDC is up 3.81% at $70.0. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 7 days.</li>
</ul>
<h3>What Analysts Are Saying About Western Digital</h3>
<p>5 market experts have recently issued ratings for this stock, with a consensus target price of $82.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $95.<br />
&#x2A; An analyst from Goldman Sachs has decided to maintain their Neutral rating on Western Digital, which currently sits at a price target of $70.<br />
&#x2A; An analyst from Wells Fargo persists with their Overweight rating on Western Digital, maintaining a target price of $85.<br />
&#x2A; Maintaining their stance, an analyst from Barclays continues to hold a Overweight rating for Western Digital, targeting a price of $80.<br />
&#x2A; Maintaining their stance, an analyst from B of A Securities continues to hold a Buy rating for Western Digital, targeting a price of $80. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Western Digital options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


Western Digital Unusual Options Activity

<p>Deep-pocketed investors have adopted a bearish approach towards Oklo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in OKLO usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 24 extraordinary options activities for Oklo. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 41% leaning bullish and 50% bearish. Among these notable options, 3 are puts, totaling $141,700, and 21 are calls, amounting to $1,137,031.</p>
<h3>Expected Price Movements</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $17.5 to $47.0 for Oklo over the last 3 months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Oklo's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Oklo's substantial trades, within a strike price spectrum from $17.5 to $47.0 over the preceding 30 days.</p>
<h3>Oklo 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1737559838_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>OKLO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$5.15</td>
<td>$5.0</td>
<td>$5.05</td>
<td>$35.00</td>
<td>$352.9K</td>
<td>2.3K</td>
<td align="right">772</td>
</tr>
<tr>
<td>OKLO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/24/25</td>
<td>$3.85</td>
<td>$3.65</td>
<td>$3.85</td>
<td>$30.00</td>
<td>$76.6K</td>
<td>3.6K</td>
<td align="right">329</td>
</tr>
<tr>
<td>OKLO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$3.85</td>
<td>$3.6</td>
<td>$3.65</td>
<td>$30.00</td>
<td>$74.3K</td>
<td>136</td>
<td align="right">206</td>
</tr>
<tr>
<td>OKLO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/28/25</td>
<td>$6.25</td>
<td>$5.8</td>
<td>$5.8</td>
<td>$30.00</td>
<td>$58.0K</td>
<td>74</td>
<td align="right">104</td>
</tr>
<tr>
<td>OKLO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/24/25</td>
<td>$3.1</td>
<td>$2.72</td>
<td>$3.1</td>
<td>$30.00</td>
<td>$53.9K</td>
<td>3.6K</td>
<td align="right">7</td>
</tr>
</tbody>
</table>
</p>
<h3>About Oklo</h3>
<p>Oklo Inc is developing advanced fission power plants to provide clean, reliable, and affordable energy at scale. It is pursuing two complementary tracks to address this demand: providing reliable, commercial-scale energy to customers; and selling used nuclear fuel recycling services to the U.S. market. The Company plans to commercialize its liquid metal fast reactor technology with the Aurora powerhouse product line. The first commercial Aurora powerhouse is designed to produce up to 15 megawatts of electricity (MWe) on both recycled nuclear fuel and fresh fuel.</p>
<p>Having examined the options trading patterns of Oklo, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Oklo's Current Market Status</h3>
<ul>
<li>With a trading volume of 7,825,192, the price of OKLO is up by 6.51%, reaching $33.28.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 22 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Oklo</h3>
<p>In the last month, 1 experts released ratings on this stock with an average target price of $31.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Citigroup persists with their Neutral rating on Oklo, maintaining a target price of $31. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Oklo options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


OKLO

Behind the Scenes of Oklo's Latest Options Trends

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>Cameco</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCJ#NYSE">CCJ</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with CCJ, it often means somebody knows something is about to happen.</p>
<p>Today, Benzinga's options scanner spotted 15 options trades for <strong>Cameco</strong>.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 66% bullish and 20%, bearish.</p>
<p>Out of all of the options we uncovered, there was 1 put, for a total amount of $40,000, and 14, calls, for a total amount of $811,190.</p>
<h3>Predicted Price Range</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $20.0 to $55.0 for Cameco over the last 3 months. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Cameco's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Cameco's whale trades within a strike price range from $20.0 to $55.0 in the last 30 days. </p>
<h3>Cameco Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1737559833_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>CCJ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$2.99</td>
<td>$2.93</td>
<td>$2.99</td>
<td>$55.00</td>
<td>$133.6K</td>
<td>7.4K</td>
<td align="right">846</td>
</tr>
<tr>
<td>CCJ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$3.15</td>
<td>$3.05</td>
<td>$3.1</td>
<td>$55.00</td>
<td>$129.9K</td>
<td>7.4K</td>
<td align="right">761</td>
</tr>
<tr>
<td>CCJ</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$38.55</td>
<td>$36.1</td>
<td>$36.3</td>
<td>$20.00</td>
<td>$108.9K</td>
<td>99</td>
<td align="right">23</td>
</tr>
<tr>
<td>CCJ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$3.15</td>
<td>$3.1</td>
<td>$3.15</td>
<td>$55.00</td>
<td>$60.4K</td>
<td>7.4K</td>
<td align="right">342</td>
</tr>
<tr>
<td>CCJ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$4.3</td>
<td>$4.2</td>
<td>$4.3</td>
<td>$55.00</td>
<td>$51.1K</td>
<td>5.9K</td>
<td align="right">578</td>
</tr>
</tbody>
</table>
</p>
<h3>About Cameco</h3>
<p>Cameco Corp is a provider of uranium needed to generate clean, reliable baseload electricity around the globe. one of those uranium producers. Cameco has three reportable segments, uranium, fuel services and Westinghouse. It derives maximum revenue from Uranium Segment. It has some projects namely; Millennium, Yeelirrie, Kintyre and Exploration. The company operates in Canada, Kazakhstan, Germany, Australia and United States.</p>
<p>Following our analysis of the options activities associated with Cameco, we pivot to a closer look at the company's own performance.</p>
<h3>Where Is Cameco Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 1,841,642, the CCJ's price is up by 2.2%, now at $54.74. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 29 days.</li>
</ul>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.</p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Cameco with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


Behind the Scenes of Cameco's Latest Options Trends

Health Care

Press Releases

Abivax Provides Update on Ulcerative Colitis (UC) Combination Therapy Program Strategy and Announces Early Preclinical Combination Data of Obefazimod and Etrasimod in Inflammatory Bowel Disease (IBD) Mouse Model

Abivax to Present Three Abstracts for Obefazimod in Ulcerative Colitis at the UEG Week 2024

Abivax Reports Positive Interim Efficacy and Safety Analysis of Once-Daily 25mg Obefazimod in Moderate to Severe Ulcerative Colitis Patients After 2-Years of Open-Label Maintenance

Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn's Disease

Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene Regulation

Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax

Comments

Abivax

Abivax (ABVX) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga